Graham Holdings(US:GHC)2025-04-30 12:32Revenue and Income - Revenue for Q1 2025 was $1,165.9 million, a 1% increase from $1,152.7 million in Q1 2024[4] - Operating income rose to $47.5 million in Q1 2025, up 34% from $35.4 million in Q1 2024[4] - Net income attributable to common shares decreased to $23.9 million ($5.45 per share) in Q1 2025, down 81% from $124.4 million ($27.72 per share) in Q1 2024[10] - The company reported a net income of $25,721,000 for Q1 2025, compared to $125,339,000 in Q1 2024[26] - The diluted income per common share, as reported, was $5.45 for Q1 2025, down from $27.72 in Q1 2024[26] Cash Flow and Expenses - Adjusted operating cash flow for Q1 2025 was $88.0 million, a 6% increase from $82.8 million in Q1 2024[4] - Adjusted Operating Cash Flow (non-GAAP) increased by 15% to $54,139,000 in Q1 2025 from $46,976,000 in Q1 2024[21] - Operating expenses decreased by 2% to $384,698,000 from $392,011,000 year-over-year[21] Segment Performance - The healthcare division saw a revenue increase of 36% to $173.7 million in Q1 2025 compared to $128.2 million in Q1 2024[17] - Higher education segment revenues grew by 10% to $88,487,000, up from $80,122,000 in the same period last year[21] - Supplemental education segment revenues increased by 5% to $75,403,000, compared to $72,122,000 in Q1 2024[21] - The company experienced a 30% increase in operating income for the supplemental education segment, reaching $5,968,000 compared to $4,580,000 in the previous year[21] Capital and Financing - The company had $864.6 million in borrowings outstanding at an average interest rate of 6.0% as of March 31, 2025[6] - Capital expenditures for Q1 2025 totaled $14.1 million, a decrease from $21.5 million in Q1 2024[4] - The company repurchased 3,978 shares of Class B common stock at a cost of $3.5 million during Q1 2025[7] Market Activity - There were no significant business acquisitions or dispositions during the first three months of 2025[5] - The company plans to continue focusing on market expansion and new product development to drive future growth[23] Gains and Losses - The company recognized net gains on marketable equity securities of $43.8 million in Q1 2025, down 58% from $104.2 million in Q1 2024[6]